Chlorine in PDB 4e1z: Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor

All present enzymatic activity of Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor:
2.7.10.2;

The structure of Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor, PDB code: 4e1z was solved by M.A.Argiriadi, R.V.Talanian, D.W.Borhani, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	21.65 / 2.50
Space group	P 31 2 1
Cell size a, b, c (Å), α, β, γ (°)	68.030, 68.030, 152.999, 90.00, 90.00, 120.00
R / Rfree (%)	19.7 / 23.7

The binding sites of Chlorine atom in the Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor (pdb code 4e1z). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor, PDB code: 4e1z:

Chlorine binding site 1 out of 1 in the Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Structure of Mouse Tyk-2 Complexed to A 3-Aminoindazole Inhibitor within 5.0Å range: probe atom residue distance (Å) B Occ A:Cl1201 b:43.4 occ:1.00 CL1 A:0MX1201 0.0 43.4 1.0 C18 A:0MX1201 1.5 38.7 1.0 C17 A:0MX1201 2.5 33.3 1.0 C19 A:0MX1201 2.5 38.3 1.0 C A:GLY905 3.6 40.2 1.0 O A:GLY905 3.6 41.6 1.0 N A:LYS906 3.8 35.3 1.0 CG1 A:VAL907 3.8 29.2 1.0 N A:VAL907 3.8 28.8 1.0 C16 A:0MX1201 3.8 33.0 1.0 CE A:LYS926 3.8 31.5 1.0 C14 A:0MX1201 3.8 38.9 1.0 C A:LYS906 3.9 35.5 1.0 CA A:LYS906 4.0 34.6 1.0 N A:GLY902 4.0 39.6 1.0 CB A:VAL907 4.1 29.5 1.0 O A:GLY900 4.1 41.6 1.0 CA A:GLY905 4.2 37.0 1.0 NZ A:LYS926 4.2 32.7 1.0 OD1 A:ASP1037 4.3 43.1 1.0 CD A:LYS926 4.3 34.1 1.0 C15 A:0MX1201 4.3 36.0 1.0 CG A:LYS926 4.4 32.3 1.0 C A:GLY900 4.4 41.9 1.0 CA A:GLU901 4.4 38.8 1.0 O A:LYS906 4.5 34.8 1.0 N A:GLU901 4.5 39.3 1.0 CA A:VAL907 4.5 27.3 1.0 C A:GLU901 4.5 43.3 1.0 CA A:GLY902 4.8 38.5 1.0 N A:GLY905 4.9 37.6 1.0

M.A.Argiriadi, E.R.Goedken, D.Banach, D.W.Borhani, A.Burchat, R.W.Dixon, D.Marcotte, G.Overmeyer, V.Pivorunas, R.Sadhukhan, S.Sousa, N.S.Moore, M.Tomlinson, J.Voss, L.Wang, N.Wishart, K.Woller, R.V.Talanian. Enabling Structure-Based Drug Design of TYK2 Through Co-Crystallization with A Stabilizing Aminoindazole Inhibitor. Bmc Struct.Biol. V. 12 22 2012.
ISSN: ESSN 1472-6807
PubMed: 22995073
DOI: 10.1186/1472-6807-12-22